Highlights Article by Danuta Loesch MD PHD, Senior Research Fellow at the School of Psychological Science, La Trobe University, Melbourne, on her current and past research into Fragile X: “Studies of Genotype-phenotype Relationships in Fragile X: Current research and a Historical Perspective” Article by Christine Kelleher our NSW Parent Support Co-ordinator on “What to do [...]

Studies have shown that female carriers of Fragile X with the pre-mutation have a higher incidence of Primary Ovarian Insufficiency (POI)*, early menopause and.ovarian dysfunction (decreased fertility). The average age of menopause is around 50 years with the majority going through it the 45-55yr age range, some as young as 40, others as old as [...]

Recently published research, which shows that a currently available drug may be useful for treating Fragile X Syndrome, is already leading to clinical trials. The drug, Minocycline, is a tetracycline antibiotic which is widely used to treat Lyme disease, acne and skin infections. Dendritic spines in the brains of those affected with Fragile X do [...]

The results of a study into conditions associated with Fragile X Syndrome have recently been published. The study, by researchers at RTI International, involved surveying parents of children with Fragile X. ( 976 full mutation males, 259 full mutation females, 57 premutation males, and 199 premutation females). Parents were asked whether their children had been [...]